2019-03-11T17:05:23-05:00 2018-06-30 363321958 Desmond & Ahern Ltd 10827 S Western Avenue Chicago IL 60643 990 2017-07-01 366009467 Orthopaedic Research and Education Foundation ORTH 8476989980 9400 W Higgins Road No 215 Rosemont IL 60018 James G Borovsky Treasurer 8476989980 2019-03-11 1 Paul Betlinski P01960501 7737794720 2019-03-11 96.84.64.45 2019-03-11 17:03:18 CD P 738B9105E46B695E191D81BBB6C655DEEDF341ED 738B9105E46B695E191D81BBB6C655DEEDF341ED 2017 2019-02-21 02:37:17Z OREF Michael L Parks MD 9400 W Higgins Road No 215 Rosemont IL 60018 9653094 0 X www.oref.org X 1955 IL Improving lives by supporting research in orthopaedic research 24 24 16 200 0 0 1915064 5448193 0 0 192213 639533 0 0 2107277 6087726 1280727 2534717 0 0 846100 1575505 0 0 843889 891257 1077279 3018084 5187501 -910807 900225 24732861 25537755 4141707 4034676 20591154 21503079 The Orthopaedic Research and Education Foundation (OREF) mission is improving lives by supporting excellence in orthopaedic research. OREF's vision is that it will be the leader in supporting orthopaedic research to improve function, eliminate pain and restore mobility. 0 0 3288934 2534717 Grant program: The purpose of OREF is to support research into the causes and treatment of musculoskeletal diseases and injuries. OREF's niche is supporting surgeon-researchers and PHD-researchers in basic science/translation, clinical, and health services research. OREF's education program offers new orthopaedic medical researchers the opportunity to develop their research interests and skills. Through educational programming, OREF supports emerging talent to help them successfully pursue research careers. 3288934 1 1 0 0 0 0 0 0 1 1 1 0 0 1 0 1 1 0 0 0 1 1 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 13 0 1 16 1 0 0 0 0 0 0 0 0 0 0 X 24 24 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 AK AL AR AZ CA CT DC DE FL GA IL IN KS KY LA MA MD ME MI MS MN MO MT NC ND NE NH NM NY OH OK OR PA RI SC SD TN UT VA WA WI WV WY X X Rhonda Dirr 8476989980 9400 W Higgins Road Rosemont IL 60018 Michael L Parks MD President 5.00 X X 0 0 0 James G Borovsky Secretary-Treasurer 5.00 X X 0 0 0 Jeffrey S Abrams MD Chair, Corporate Advisory Committee 5.00 X 0 0 0 David C Dvorak JD Vice Chair, Corp Advisory Committee 5.00 X 0 0 0 Matthew B Dobbs MD Vice Chair-Grants 5.00 X 0 0 0 Joshua J Jacobs Chair-Mentorship Champ/Treas-elect 5.00 X 0 0 0 Farshid Guilak MD Chair-Grants 5.00 X 0 0 0 Richard F Santore MD Chair-Individual Development 5.00 X 0 0 0 Mary Lloyd Ireland MD Chair-Annual Fund 5.00 X 0 0 0 Letha Y Griffin MD PhD Chair-Communications Committee 5.00 X 0 0 0 Richard F Kyle MD President-elect 5.00 X X 0 0 0 David G Lewallen MD Past President (2018-2019) 5.00 X X 0 0 0 John J Callaghan MD Past President (2017-2018) 5.00 X X 0 0 0 Christopher R Adams MD Trustee 5.00 X 0 0 0 Jeremie M Axe MD Trustee 5.00 X 0 0 0 B Sonny Bal MD JD MBA PhD Trustee 5.00 X 0 0 0 John A Bergfeld MD Trustee 5.00 X 0 0 0 Nicholas M Bernthal MD Trustee 5.00 X 0 0 0 Paul C Collins MD Trustee 5.00 X 0 0 0 Eric V Dremel Trustee 5.00 X 0 0 0 James R Ficke MD Trustee 5.00 X 0 0 0 Karen L Hackett Trustee 5.00 X 0 0 0 Lawrence L Lenke MD Trustee 5.00 X 0 0 0 Timothy J Luchetti MD Trustee 5.00 X 0 0 0 William C McMaster MD Trustee 5.00 X 0 0 0 Andrew N Pollak MD Trustee 5.00 X 0 0 0 Thomas P Sculo MD Trustee 5.00 X 0 0 0 John R Tongue MD Trustee 5.00 X 0 0 0 P Joanne Ray Chief Executive Officer thru 8/2018 50.00 X 140978 0 11037 Edward Hoover Senior Vice President of Development 40.00 X 133009 0 14515 Carol Wargo Vice President of Corporate 40.00 X 143502 0 14514 Karen Pubentz Sr. Director of Communications 40.00 X 113335 0 21151 Ponda Barnes Vice President of Grants 40.00 X 113683 0 11325 644507 0 72542 5 0 1 0 0 5448193 21468 5448193 506240 506240 3698661 3565368 133293 133293 133293 6087726 0 0 639533 2484947 2484947 49770 49770 246927 27162 140748 79017 1052385 309004 458149 285232 81896 22148 37045 22703 99274 26612 45079 27583 95023 24706 43711 26606 26918 523 21336 5059 25320 25320 34630 17315 17315 86299 25809 21365 39125 134664 53399 3006 78259 68566 17827 31540 19199 106032 27568 48775 29689 127902 27299 64367 36236 50017 2794 33902 13321 173566 96695 20737 56134 41011 10663 18865 11483 93089 64146 23386 5557 Bad debt 68387 68387 Miscellaneous 19461 2188 17273 Other 10847 10847 Dues and subscriptions 5298 205 3783 1310 5272 342 529 4401 5187501 3288934 1054678 843889 451983 465434 2084350 2784754 2232849 3056939 39908 52573 245168 138221 131187 106947 14778861 14772453 5013723 4298655 24732861 25537755 176377 201547 2691038 3134087 1274292 699042 4141707 4034676 X -2505924 -2062873 6775392 7285463 16321686 16280489 20591154 21503079 24732861 25537755 X 900225 250930 -239230 X 0 1 X 1 0 X 6370076 4520407 5097325 4715824 5448193 26151825 6370076 4520407 5097325 4715824 5448193 26151825 2916457 23235368 872830 904836 805283 431365 506240 3520554 29672379 0.78310 0.81620 X 0 1 X 8014335 46789 250683 8311807 7306263 10723 778493 81144 8014335 12835718 48562 953270 6230393 271935 28959 7306263 22513404 62327 -2148068 7564692 27250 12835721 26167534 103477 535123 260879 4031854 22513401 1.00000 0 0 50447 18541 31906 130696 85275 45421 64025 34405 29620 106947 Charitable Remainder Trust Receivable 2571120 Cash Surrender Value of Life Insurance 1708744 Other receivables 18791 4298655 X 6145210 250930 -193446 57484 6087726 0 6087726 5233285 45784 45784 5187501 0 5187501 Part IV, Line 2b: On behalf of other orthopaedic organizations, the Foundation accepts contributions for which it performs recordkeeping and provides grants requested by those organizations. Part X, Line 2: FIN48 Note from Audited Financial Statements The Foundation, an Illinois nonprofit corporation, is exempt from income taxes under Section 501(c)(3) of the Internal Revenue Code and applicable state law, except for taxes pertaining to unrelated business income, if any. The Foundation's annual information and income tax returns filed with the federal and state governments are subject to examination generally for three years after they are filed. The Foundation has adopted the requirements for accounting for uncertain tax positions and management has determined that the Foundation was not required to record a liability related to uncertain tax positions as of June 30, 2018. Part XI, Line 2d - Other Adjustments: Change in cash surrender value of life insurance policies 593. Change in charitable remainder trust receivable -194,039. Part XII, Line 2d - Other Adjustments: Orthopaedic partner endowment distribution 45,784. 0 North America 0 0 Research grant-The Impact of Psychological Factors on the Outcome of Rotator Cuff Repair Grant 49770 0 0 0 0 0 0 49770 0 49770 North America The Impact of Psychological Factors on the Outcome of Rotator Cuff Repair 49770 0 0 0 0 0 0 1 Baylor College of Medicine 6620 Main Street Houston TX 77030 741613878 501(c)(3) 5000 Isolation and Identification of Human Periosteal Skeletal Stem Cells Cedars-Sinai Medical Center 8797 Beverly Blvd Los Angeles CA 90048 951644600 501(c)(3) 20000 Identifying and Mitigating the Effects of Diabetes on Disc Degeneration Cleveland Clinic Foundation 9500 Euclid Avenue Cleveland OH 44195 340714585 501(c)(3) 5000 Telemedicine in Total Knee Arthroplasty using Wearable Technology Cleveland Clinic Foundation 9500 Euclid Avenue Cleveland OH 44195 340714585 501(c)(3) 49997 Understanding the Role of Glucose and Myoinositol in Tendinopathy Columbia University Medical Center 6300 West 168th Street New York NY 10032 135598093 501(c)(3) 5000 T1-rho MRI Evaluation of Glenohumeral Cartilage After Instability Repair Columbia University Medical Center 6300 West 168th Street New York NY 10032 135598093 501(c)(3) 5000 Arthroscopic Technique for Implantation of tissue Engineered Scaffold Dartmouth College 1 Medical Center Drive Lebanon NH 27710 020222111 501(c)(3) 5000 An In Vitro Study of the Wear Characteristics of Polyethylene on Bone Duke University 375 MSRB Research Drive Durham NC 27710 560532129 501(c)(3) 50000 Multicenter Randomized Trial of Home vs. PT Rehabilitation for Reverse TSA Duke University 375 MSRB Research Drive Durham NC 27710 560532129 501(c)(3) 98000 Improving Meniscus Repair Using a Meniscus-derived Matrix Allograft Hospital for Special Surgery 535 East 17th Street New York NY 10021 131624135 501(c)(3) 5000 Effect of Medial Procedures on Reconstruction of the Adolescent Flatfoot Hospital for Special Surgery 535 East 17th Street New York NY 10021 131624135 501(c)(3) 20000 Novel Radiographic Views of the Scaphotrapezial Joint Hospital for Special Surgery 535 East 17th Street New York NY 10021 131624135 501(c)(3) 135000 Effect of Operative Team Consistency on Patient Safety and Efficiency Hospital for Special Surgery 535 East 17th Street New York NY 10021 131624135 501(c)(3) 799747 SVFC Therapy to Improve Rotator cuff Tears: A Phase II Clinical Trial Icahn School of Medicine at Mount Sinai One Gustave L Levy Place New York NY 10029 136171197 501(c)(3) 5000 The role of decorin delivery in rotator cuff tendon healing Kaiser Permanente 100 S Los Robles 2nd FL Pasadena CA 91101 951750445 501(c)(3) 20000 Optimizing Anterior Cruciate Ligament Reconstruction: Individualizing the Decision Making Process Using Data from the Kaziser Permanente ACLR Registry Mayo Clinic 200 First Street SW Rochester MN 55905 416011702 501(c)(3) 90000 Robotically-Assisted vs Manual-Executed Total Knee Arthroplasty NYU Hospital for Joint Diseases 301 East 17th Street New York NY 10003 135562308 501(c)(3) 20000 CRLF1 and Mesenchymal Stem Cell Injection in a Rabbit Osteochondral Defect Pennsylvania State University PO Box 850 Hershey PA 17033 246000376 501(c)(3) 5000 Consequences of Glenoid Performation and Cement Extrusion in Total Shoulder Stanford University 450 Broadway Street Redwood City CA 64063 941156365 501(c)(3) 50000 Bacteriophage: A Novel Approach to Periprosthetic Joint Infection Thomas Jefferson University Rothman Institute 125 S 9th Street Sheridan Philadelphia PA 19107 231352651 501(c)(3) 5000 Prevention of P. Acnes with Hydrogen Peroxide Prep for Shoulder Surgery University of California San Francisco 3333 California St San Francisco CA 94143 946036493 501(c)(3) 5000 The Impact of Early Sport Specialization on the Collegiate Athlete University of Kansas - Kansas City 3901 Rainbow Blvd Kansas City KS 66103 481108830 501(c)(3) 20000 Effect of Cartilage-specific NFAT1 Expression on Post-traumatic Arthritis University of Michigan 200 Zina Pitcher Ann Arbor MI 49109 386006309 501(c)(3) 225000 A Closed-Loop Gene Circuit to Enhance Articular Cartilage Regeneration University of Minnesota - Twin Cities 200 Oak Street NE Minneapolis MN 55455 416007513 501(c)(3) 19534 Microenvironmental Influences on Articular Chondrocyte Differentiation University of Pennsylvania 3451 Walnut St Philadelphia PA 19104 231352685 501(c)(3) 5000 Do low profile distal radius plates decrease rates of FPL rupture? University of Pittsburgh 123 University Place Pittsburgh PA 15312 250965591 501(c)(3) 20000 Periprosthetic Joint Infection Biofilm Antibiotic Tolerance University of Pittsburgh 123 University Place Pittsburgh PA 15312 250965591 501(c)(3) 300000 Antibiotic Tolerant Biofilms in Periprosthetic Joint Infection University of Washington 325 Ninth Avenue Seattle WA 98104 916001537 501(c)(3) 150000 Antibiotic Tolerant Biofilms in Periprosthetic Joint Infection Vanderbilt University 3319 West End Ave Nashville TN 37203 162047682 501(c)(3) 5000 Intra-Articular Doxycycline: A Novel Treatment of Adhesive Capsulitis Washington University in St Louis One Brookings Drive St Louis MO 63130 430653611 501(c)(3) 5000 Long-Term Results and Incidence of Osteolysis of Young THA Patients Washington University in St Louis One Brookings Drive St Louis MO 63130 430653611 501(c)(3) 20000 Gene Expression of Medial Meniscus Tears and Development of Osteoarthritis Washington University in St Louis One Brookings Drive St Louis MO 63130 430653611 501(c)(3) 50000 Intra-articular Metabolic Activity in the Pre-Osteoarthritic Hip Washington University in St Louis One Brookings Drive St Louis MO 63130 430653611 501(c)(3) 225000 Can Early Evidence of OA After ACL Injury be Measured and Modified? 33 0 Part I, Line 2: The Research Grants Committee is responsible for allocating research funding to advance research in the specialty of orthopaedics and is empowered to establish criteria for the allocation and distribution of philanthropic funds to advance research in the specialty of orthopaedics, implement and conduct independent peer review process to select research funding recipients, prepare and distribute necessary promotional information and application forms for research grants and awards and to accept and allocate or decline to allocate, at its sole and absolute discretion, grants and awards for research. One-year grant recipients receive 50% of the funds to start, then 40% after a six-month financial report is received. A final scientific and lay report within 60 days after the grant ends along with a final financial report is required. Once OREF has the final reports the remaining 10% of the funds are released. One-time award/educational grant/lectureship grants receive full payment after they are approved. Documentation is in the file for lectureships, educational programs and awards. Two or three-year grants are paid and spread over the term of the grant. 10% is withheld until all of the reports are received. Multi-year grant recipients submit annual scientific reports which are then reviewed by the original peer review committee member. X X 0 0 0 0 0 0 0 0 0 P Joanne Ray Chief Executive Officer thru 8/2018 140978 0 0 0 0 0 5700 0 5337 0 152015 0 0 0 Carol Wargo Vice President of Corporate 143502 0 0 0 0 0 11343 0 3171 0 158016 0 0 0 Form 990, Part VI, Section B, line 11b The Audit Committee reviewed and approved the Form 990. It is provided to the Board of Directors, who had an opportunity to review the return prior to filing. Form 990, Part VI, Section B, line 12c All Trustees annual conflict of interest statements are on file with the OREF CEO. The CEO reviews meeting agendas prior to the meeting and notifies leadership of any issues that need to be addressed before the discussions take place. Any individual who gives notice of a potential conflict is to abstain from participation in discussions related to that item. Form 990, Part VI, Section B, line 15 The Foundation has a formal process to determine the compensation of its CEO. The process includes the following: 1) Review and approval by the Board of Trustees or Compensation Committee; 2) Use of comparable compensation data; 3) Contemporaneous documentation and record keepping. Form 990, Part VI, Section C, line 19 The Foundation made its governing documents, conflict of interest policy, and financial statements available to the public upon request for the period of disclosure set forth in IRC Section 6104(d). Form 990, Part XI, line 9: Orthopaedic partner endowment distribution -45,784. Change in cash surrender value of life insurance policies 593. Change in charitable remainder trust receivable -194,039. Charitable Remainder Trusts Charitable trusts IL T 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0